Loading…

Hologic received a $119 million contract from HHS and the Department of Defense to scale up COVID-19 test manufacturing capacity. The funding will enable Hologic to produce 13 million COVID-19 tests per month in the U.S. by January 2022, up from 6 million globally as of July 2020.
“We believe this expansion at least doubles [Hologic's] current COVID-19 test capacity in the US, and should enable the company to produce >55MM total molecular tests/quarter vs. the previously disclosed capacity of ~40MM/quarter.”medtechdive.com
Summarized from public sources; check the original articles before acting on it.